feed,title,long_url,short_url
SeekingAlpha,Dynavax reports 46% Y/Y increase in HEPLISAV-B vaccine net product revenue,https://seekingalpha.com/news/4053172,
SeekingAlpha,Sarepta Therapeutics provides Q4 and FY forecast,https://seekingalpha.com/news/4053171,
